Last Updated：2025/12/06
The clinical trial showed that gilteritinib significantly improved survival in patients with relapsed acute myeloid leukemia.
See correct answer
The clinical trial showed that gilteritinib significantly improved survival in patients with relapsed acute myeloid leukemia.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
